revlimid.com
#2,497,242
Global Rankeez rank — last updated 01 Oct 2026
Better than 97.5% of the 99,976,913 domains we track
Best rank recorded
#2,497,242
2026-10
Worst rank recorded
#13,715,047
2026-07
Tracked since
2026-07
3 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how revlimid.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #3,419,129 |
| Majestic Million (ranked by referring subnets) | #631,039 |
| CommonCrawl (hyperlink graph) | #2,208,529 |
See how these sources are combined and cross-validated →
Ranking history
revlimid.com's rank across 3 monthly snapshots. ▲ improved by 11,217,805 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #13,715,047 |
| 2026-08 | #13,707,729 |
| 2026-10 | #2,497,242 |
JSON API
{
"revlimid.com": 2497242,
"history": {
"2026-07": 13715047,
"2026-08": 13707729,
"2026-10": 2497242
}
}
GET https://rankeez.com/api/revlimid.com.json · see API docs →
More about revlimid.com
revlimid.com — page content & similar sites →
About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information.
revlimid.com — full site profile →
WHOIS, tech stack and extended traffic history for revlimid.com.